Theranostics Applications of Nanoparticles in Cancer Immunotherapy

With the advancement in the mechanism of immune surveillance and immune evasion in cancer cells, cancer immunotherapy shows promising results for treating cancer with established efficacy and less toxicity. As a result of the off-target effect, the approach for delivering vaccines, adjuvants, or ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yihai, Wang, Xixi, Hussain, Mubashir, Lv, Mu, Dong, Xiaohan, Wang, Tianying, Xu, Xueqin, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313674/
https://www.ncbi.nlm.nih.gov/pubmed/30424010
http://dx.doi.org/10.3390/medsci6040100
_version_ 1783383987715047424
author Liu, Yihai
Wang, Xixi
Hussain, Mubashir
Lv, Mu
Dong, Xiaohan
Wang, Tianying
Xu, Xueqin
Liu, Bin
author_facet Liu, Yihai
Wang, Xixi
Hussain, Mubashir
Lv, Mu
Dong, Xiaohan
Wang, Tianying
Xu, Xueqin
Liu, Bin
author_sort Liu, Yihai
collection PubMed
description With the advancement in the mechanism of immune surveillance and immune evasion in cancer cells, cancer immunotherapy shows promising results for treating cancer with established efficacy and less toxicity. As a result of the off-target effect, the approach for delivering vaccines, adjuvants, or antibodies directly to tumor sites is gaining widespread attention. An effective alternative is to utilize nanoengineered particles, functioning as drug-delivery systems or as antigens themselves. This article reviews the practical implementation of nanotechnology in cancer immunotherapy.
format Online
Article
Text
id pubmed-6313674
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63136742019-01-04 Theranostics Applications of Nanoparticles in Cancer Immunotherapy Liu, Yihai Wang, Xixi Hussain, Mubashir Lv, Mu Dong, Xiaohan Wang, Tianying Xu, Xueqin Liu, Bin Med Sci (Basel) Review With the advancement in the mechanism of immune surveillance and immune evasion in cancer cells, cancer immunotherapy shows promising results for treating cancer with established efficacy and less toxicity. As a result of the off-target effect, the approach for delivering vaccines, adjuvants, or antibodies directly to tumor sites is gaining widespread attention. An effective alternative is to utilize nanoengineered particles, functioning as drug-delivery systems or as antigens themselves. This article reviews the practical implementation of nanotechnology in cancer immunotherapy. MDPI 2018-11-09 /pmc/articles/PMC6313674/ /pubmed/30424010 http://dx.doi.org/10.3390/medsci6040100 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Liu, Yihai
Wang, Xixi
Hussain, Mubashir
Lv, Mu
Dong, Xiaohan
Wang, Tianying
Xu, Xueqin
Liu, Bin
Theranostics Applications of Nanoparticles in Cancer Immunotherapy
title Theranostics Applications of Nanoparticles in Cancer Immunotherapy
title_full Theranostics Applications of Nanoparticles in Cancer Immunotherapy
title_fullStr Theranostics Applications of Nanoparticles in Cancer Immunotherapy
title_full_unstemmed Theranostics Applications of Nanoparticles in Cancer Immunotherapy
title_short Theranostics Applications of Nanoparticles in Cancer Immunotherapy
title_sort theranostics applications of nanoparticles in cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313674/
https://www.ncbi.nlm.nih.gov/pubmed/30424010
http://dx.doi.org/10.3390/medsci6040100
work_keys_str_mv AT liuyihai theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT wangxixi theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT hussainmubashir theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT lvmu theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT dongxiaohan theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT wangtianying theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT xuxueqin theranosticsapplicationsofnanoparticlesincancerimmunotherapy
AT liubin theranosticsapplicationsofnanoparticlesincancerimmunotherapy

Ejemplares similares